ipo news - Search News

Venture Global’s Stumble Reflects Chilly State of IPO Market

Hosted on MSN · 7h

Venture Global stock sinks on IPO day, indicating lack of investor interest in the LNG exporter

The stock market trading debut comes as incoming President Trump has said he plans to boost America’s energy production. Update Friday, 3:30 p.m.

Venture Global IPO Signals A Return To Normal Order For LNG Exports

Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.

Wall Street Journal · 1d

Venture Global’s Stumble Reflects Chilly State of the IPO Market

Venture Global launched its initial public offering with a lofty goal: Raise up to $2.3 billion at a $110 billion valuation in the biggest stock-market debut since summer. The market had different plans.

Ascentage Pharma raises $126m in 1st biotech IPO of 2025

Bloomberg L.P. · 1d

Ascentage Pharma’s US Shares Climb After $126 Million IPO

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s US trading debut, after pricing its $126.4 million initial public offering at a discount to its Asian stock.

Investing.com on MSN · 1d

Ascentage Pharma IPO opens flat

IPO began trading Friday on the NASDAQ. Shares opened at $17.25 per ADS, in line with the initial public offering (IPO) price of $17.25. The pharmaceutical company, already listed on the Main Board of the Stock Exchange of Hong Kong Limited under the code 6855.

Seeking Alpha on MSN · 1d

Takeda-backed Ascentage Pharma prices $126M U.S. IPO

Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 per share,

1d

IPO market comeback: How recent major US listings fared

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

16h

U.S. IPO Weekly Recap: Venture Global Prices A Pared-Down IPO As More Sizable Deals Join The Pipeline

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

4h

Upcoming IPO: Dorf-Ketal Chemicals files IPO draft papers with Sebi for ₹5,000 crore IPO

Specialty chemicals manufacturer Dorf-Ketal Chemicals India Ltd has submitted preliminary documents to the Securities and ...

2d

Castle Creek-backed Northpointe Bancshares files for US IPO

Private equity-backed Northpointe Bancshares filed for an initial public offering in the United States on Thursday, setting ...

1d

Bain-Backed Sustainable Fuel Producer EcoCeres Eyes Europe IPO

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

17h

One and Only IPO in February 2025? Check Details

The company's public listing is set to attract attention as it aims to raise Rs 600 crore with shares priced between Rs ...

1d

3FPX, ARM : IPO Rebound In 2025? Here's What's Fueling The Boom,...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...

1don MSN

Even Trump Couldn’t Save This Energy IPO

U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results